IMMUTEP LIMITED - Announcements

0.00%

26.0¢

Market Cap $381.6M

Healthcare Biotechnology

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IMM	Immutep to present at February Investor Conferences		31/01/22	224.65KB	Share
IMM	Immutep Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	25/01/22	508.96KB	Share
IMM	Change in substantial holding		05/01/22	904.51KB	Share
IMM	Immutep Advances IMP761 Manufacturing	PRICE SENSITIVE	16/12/21	264.78KB	Share
IMM	Change of Registered Office Address		14/12/21	202.27KB	Share
IMM	Amended Constitution		14/12/21	731.04KB	Share
IMM	Change in substantial holding		06/12/21	842.01KB	Share
IMM	Notification regarding unquoted securities - IMM		02/12/21	23.89KB	Share
IMM	Good safety reported from 1st five patients in INSIGHT-003	PRICE SENSITIVE	02/12/21	222.59KB	Share
IMM	Change of Director's Interest Notice - Dr. Howard		01/12/21	215.96KB	Share
IMM	Change of Director's Interest Notice - Mr Voigt		01/12/21	215.68KB	Share
IMM	Application for quotation of securities - IMM		01/12/21	25.01KB	Share
IMM	Proposed issue of securities - IMM		30/11/21	24.86KB	Share
IMM	Notification regarding unquoted securities - IMM		30/11/21	26.88KB	Share
IMM	Results of Meeting		26/11/21	257.36KB	Share
IMM	Immutep AGM 2021 - CEO's Presentation		26/11/21	1.17MB	Share
IMM	Immutep AGM 2021 - Chairman's Address		26/11/21	221.43KB	Share
IMM	Phase II TACTI-002 trial recruitment successfully completed	PRICE SENSITIVE	19/11/21	270.67KB	Share
IMM	Change in substantial holding		17/11/21	2.55MB	Share
IMM	Immutep Global Webcast Slides to Discuss Clinical Results	PRICE SENSITIVE	17/11/21	2.78MB	Share
IMM	Change in substantial holding		16/11/21	258.43KB	Share
IMM	Immutep announces publication of SITC 2021 posters	PRICE SENSITIVE	15/11/21	562.84KB	Share
IMM	Chinese Patent Granted for Efti with PD-1 Pathway Inhibitors	PRICE SENSITIVE	15/11/21	214.36KB	Share
IMM	Immutep announces publication of SITC 2021 abstracts	PRICE SENSITIVE	10/11/21	295.44KB	Share
IMM	Final Phase IIb AIPAC clinical trial results for Efti in MBC	PRICE SENSITIVE	10/11/21	328.34KB	Share
IMM	JobKeeper Payment Notice		08/11/21	245.01KB	Share
IMM	Immutep granted Chinese Patent for eftilagimod alpha	PRICE SENSITIVE	02/11/21	228.26KB	Share
IMM	Immutep receives EMA scientific advice for Phase 3 in MBC	PRICE SENSITIVE	29/10/21	253.2KB	Share
IMM	Immutep Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	28/10/21	529.49KB	Share
IMM	Notice of Annual General Meeting/Proxy Form		26/10/21	836.94KB	Share
IMM	Appendix 4G		26/10/21	289.32KB	Share
IMM	Annual Report to shareholders		26/10/21	1.03MB	Share
IMM	Annual Report filed on Form 20-F with SEC		26/10/21	674.39KB	Share
IMM	2021 AGM & Key Dates		12/10/21	263.02KB	Share
IMM	Ceasing to be a substantial holder from AEF		07/10/21	194.7KB	Share
IMM	Change of Director's Interest Notice - Mr Chamberlain		04/10/21	211.04KB	Share
IMM	Change of Director's Interest Notice - Mr Meyers		04/10/21	214.67KB	Share
IMM	Immutep to present Phase II TACTI-002 data at SITC 2021		04/10/21	291.14KB	Share
IMM	Notification regarding unquoted securities - IMM		01/10/21	24.94KB	Share
IMM	Application for quotation of securities - IMM		01/10/21	25.94KB	Share
IMM	Immutep Receives A$3.4 million R&D French Tax Incentive	PRICE SENSITIVE	29/09/21	227.51KB	Share
IMM	Immutep to Present at Healthcare Investor Conferences		28/09/21	220.23KB	Share
IMM	Immutep Corporate Presentation		27/09/21	2.3MB	Share
IMM	Immutep to present final AIPAC Overall Survival data at SITC		21/09/21	252.48KB	Share
IMM	Recruitment of patients completed for Part B of TACTI-002	PRICE SENSITIVE	01/09/21	264.68KB	Share
IMM	Immutep's partner, EOC Pharma, expands efti trial pipeline	PRICE SENSITIVE	31/08/21	224.87KB	Share
IMM	Appendix 4E & 2021 Full Year Statutory Accounts	PRICE SENSITIVE	30/08/21	1.39MB	Share
IMM	Chinese patent granted for anti-LAG-3 antibody LAG525	PRICE SENSITIVE	27/08/21	228.89KB	Share
IMM	INSIGHT-003 investigator-initiated trial - 1st patient dosed	PRICE SENSITIVE	05/08/21	243.04KB	Share
IMM	Becoming a substantial holder		03/08/21	195.21KB	Share
IMM	Change in substantial holding		03/08/21	922.62KB	Share
IMM	Cleansing Notice		30/07/21	233.42KB	Share
IMM	Completion of Placement - Tranche 2	PRICE SENSITIVE	30/07/21	281.11KB	Share
IMM	Application for quotation of securities - IMM		29/07/21	23.23KB	Share
IMM	Change in substantial holding		27/07/21	913.6KB	Share
IMM	Proposed issue of securities - IMM		27/07/21	25.33KB	Share
IMM	Results of EGM		26/07/21	224.47KB	Share
IMM	Chairman's EGM Address		26/07/21	205.96KB	Share
IMM	2021 EGM Presentation		26/07/21	1.52MB	Share
IMM	Application for quotation of securities - IMM		23/07/21	24.58KB	Share
IMM	Change in substantial holding		23/07/21	1.89MB	Share
IMM	Completion of Share Purchase Plan	PRICE SENSITIVE	21/07/21	273.73KB	Share
IMM	EGM - Now to be Held as an Online Virtual Meeting		15/07/21	238.59KB	Share
IMM	Immutep Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	13/07/21	499.68KB	Share
IMM	US FDA & IRB approves start of ph2b head & neck cancer trial	PRICE SENSITIVE	06/07/21	235.94KB	Share
IMM	Proposed issue of securities - IMM		05/07/21	28.21KB	Share
IMM	Change in substantial holding from AEF		30/06/21	179.63KB	Share
IMM	Change in substantial holding		30/06/21	905.65KB	Share
IMM	Cleansing Notice		28/06/21	233.27KB	Share
IMM	Notice of Extraordinary General Meeting/Proxy Form		25/06/21	525.46KB	Share
IMM	Share Purchase Plan Offer Documents		25/06/21	1.06MB	Share
IMM	Application for quotation of securities - IMM		25/06/21	23.34KB	Share
IMM	Efti to be evaluated in new triple combination therapy trial	PRICE SENSITIVE	21/06/21	230.43KB	Share
IMM	Proposed issue of securities - IMM		21/06/21	25.41KB	Share
IMM	Immutep Capital Raising Presentation	PRICE SENSITIVE	21/06/21	3.01MB	Share
IMM	Immutep secures commitments for A$60 million in a Placement	PRICE SENSITIVE	21/06/21	361.64KB	Share
IMM	Trading Halt	PRICE SENSITIVE	17/06/21	258.72KB	Share
IMM	Change in substantial holding		15/06/21	2.25MB	Share
IMM	Immutep global webcast slides	PRICE SENSITIVE	09/06/21	2.53MB	Share
IMM	Appendix 2A		08/06/21	66.12KB	Share
IMM	Immutep Reveals a New anti-LAG-3 Research Program	PRICE SENSITIVE	08/06/21	244.44KB	Share
IMM	Application for quotation of securities - IMM		07/06/21	24.92KB	Share
IMM	Immutep presentation for Jefferies Healthcare Conference		04/06/21	2.25MB	Share
IMM	Immutep Reports Positive Data from its TACTI-002 ph 2 trial	PRICE SENSITIVE	04/06/21	311.58KB	Share
IMM	Immutep Reports Positive Final Data from INSIGHT-004 trial	PRICE SENSITIVE	04/06/21	250.79KB	Share
IMM	Immutep granted European patent for its LAG-3 candidate Efti	PRICE SENSITIVE	02/06/21	228.93KB	Share
IMM	Immutep enters New Collaboration with Merck KGaA for Efti	PRICE SENSITIVE	01/06/21	234.09KB	Share
IMM	Immutep granted Chinese patent for its LAG-3 candidate Efti	PRICE SENSITIVE	26/05/21	227.66KB	Share
IMM	Immutep to present at Jefferies Healthcare Conference		25/05/21	215.04KB	Share
IMM	TACTI-002 and INSIGHT-004 abstracts for ASCO 2021		20/05/21	309.91KB	Share
IMM	Change in substantial holding		20/05/21	1.88MB	Share
IMM	Change in substantial holding		18/05/21	1.9MB	Share
IMM	Appendix 2A		14/05/21	285.13KB	Share
IMM	Immutep Corporate Presentation		13/05/21	3.42MB	Share
IMM	Operational Update	PRICE SENSITIVE	07/05/21	250.68KB	Share
IMM	TACTI-002 & INSIGHT-004 data to be presented at ASCO	PRICE SENSITIVE	29/04/21	315.08KB	Share
IMM	Immutep Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	19/04/21	570.75KB	Share
IMM	Immutep receives A$1,155,055 R&D Tax Incentive	PRICE SENSITIVE	16/04/21	211.28KB	Share
IMM	Immutep Investor Update		14/04/21	1.83MB	Share
IMM	Immutep achieves Fast Track designation for Efti from US FDA	PRICE SENSITIVE	08/04/21	251.23KB	Share

IMM Immutep to present at February Investor Conferences
31/01/22		224.65KB	Share
IMM Immutep Quarterly Activities Report and Appendix 4C
25/01/22	PRICE SENSITIVE	508.96KB	Share
IMM Change in substantial holding
05/01/22		904.51KB	Share
IMM Immutep Advances IMP761 Manufacturing
16/12/21	PRICE SENSITIVE	264.78KB	Share
IMM Change of Registered Office Address
14/12/21		202.27KB	Share
IMM Amended Constitution
14/12/21		731.04KB	Share
IMM Change in substantial holding
06/12/21		842.01KB	Share
IMM Notification regarding unquoted securities - IMM
02/12/21		23.89KB	Share
IMM Good safety reported from 1st five patients in INSIGHT-003
02/12/21	PRICE SENSITIVE	222.59KB	Share
IMM Change of Director's Interest Notice - Dr. Howard
01/12/21		215.96KB	Share
IMM Change of Director's Interest Notice - Mr Voigt
01/12/21		215.68KB	Share
IMM Application for quotation of securities - IMM
01/12/21		25.01KB	Share
IMM Proposed issue of securities - IMM
30/11/21		24.86KB	Share
IMM Notification regarding unquoted securities - IMM
30/11/21		26.88KB	Share
IMM Results of Meeting
26/11/21		257.36KB	Share
IMM Immutep AGM 2021 - CEO's Presentation
26/11/21		1.17MB	Share
IMM Immutep AGM 2021 - Chairman's Address
26/11/21		221.43KB	Share
IMM Phase II TACTI-002 trial recruitment successfully completed
19/11/21	PRICE SENSITIVE	270.67KB	Share
IMM Change in substantial holding
17/11/21		2.55MB	Share
IMM Immutep Global Webcast Slides to Discuss Clinical Results
17/11/21	PRICE SENSITIVE	2.78MB	Share
IMM Change in substantial holding
16/11/21		258.43KB	Share
IMM Immutep announces publication of SITC 2021 posters
15/11/21	PRICE SENSITIVE	562.84KB	Share
IMM Chinese Patent Granted for Efti with PD-1 Pathway Inhibitors
15/11/21	PRICE SENSITIVE	214.36KB	Share
IMM Immutep announces publication of SITC 2021 abstracts
10/11/21	PRICE SENSITIVE	295.44KB	Share
IMM Final Phase IIb AIPAC clinical trial results for Efti in MBC
10/11/21	PRICE SENSITIVE	328.34KB	Share
IMM JobKeeper Payment Notice
08/11/21		245.01KB	Share
IMM Immutep granted Chinese Patent for eftilagimod alpha
02/11/21	PRICE SENSITIVE	228.26KB	Share
IMM Immutep receives EMA scientific advice for Phase 3 in MBC
29/10/21	PRICE SENSITIVE	253.2KB	Share
IMM Immutep Quarterly Activities Report & Appendix 4C
28/10/21	PRICE SENSITIVE	529.49KB	Share
IMM Notice of Annual General Meeting/Proxy Form
26/10/21		836.94KB	Share
IMM Appendix 4G
26/10/21		289.32KB	Share
IMM Annual Report to shareholders
26/10/21		1.03MB	Share
IMM Annual Report filed on Form 20-F with SEC
26/10/21		674.39KB	Share
IMM 2021 AGM & Key Dates
12/10/21		263.02KB	Share
IMM Ceasing to be a substantial holder from AEF
07/10/21		194.7KB	Share
IMM Change of Director's Interest Notice - Mr Chamberlain
04/10/21		211.04KB	Share
IMM Change of Director's Interest Notice - Mr Meyers
04/10/21		214.67KB	Share
IMM Immutep to present Phase II TACTI-002 data at SITC 2021
04/10/21		291.14KB	Share
IMM Notification regarding unquoted securities - IMM
01/10/21		24.94KB	Share
IMM Application for quotation of securities - IMM
01/10/21		25.94KB	Share
IMM Immutep Receives A$3.4 million R&D French Tax Incentive
29/09/21	PRICE SENSITIVE	227.51KB	Share
IMM Immutep to Present at Healthcare Investor Conferences
28/09/21		220.23KB	Share
IMM Immutep Corporate Presentation
27/09/21		2.3MB	Share
IMM Immutep to present final AIPAC Overall Survival data at SITC
21/09/21		252.48KB	Share
IMM Recruitment of patients completed for Part B of TACTI-002
01/09/21	PRICE SENSITIVE	264.68KB	Share
IMM Immutep's partner, EOC Pharma, expands efti trial pipeline
31/08/21	PRICE SENSITIVE	224.87KB	Share
IMM Appendix 4E & 2021 Full Year Statutory Accounts
30/08/21	PRICE SENSITIVE	1.39MB	Share
IMM Chinese patent granted for anti-LAG-3 antibody LAG525
27/08/21	PRICE SENSITIVE	228.89KB	Share
IMM INSIGHT-003 investigator-initiated trial - 1st patient dosed
05/08/21	PRICE SENSITIVE	243.04KB	Share
IMM Becoming a substantial holder
03/08/21		195.21KB	Share
IMM Change in substantial holding
03/08/21		922.62KB	Share
IMM Cleansing Notice
30/07/21		233.42KB	Share
IMM Completion of Placement - Tranche 2
30/07/21	PRICE SENSITIVE	281.11KB	Share
IMM Application for quotation of securities - IMM
29/07/21		23.23KB	Share
IMM Change in substantial holding
27/07/21		913.6KB	Share
IMM Proposed issue of securities - IMM
27/07/21		25.33KB	Share
IMM Results of EGM
26/07/21		224.47KB	Share
IMM Chairman's EGM Address
26/07/21		205.96KB	Share
IMM 2021 EGM Presentation
26/07/21		1.52MB	Share
IMM Application for quotation of securities - IMM
23/07/21		24.58KB	Share
IMM Change in substantial holding
23/07/21		1.89MB	Share
IMM Completion of Share Purchase Plan
21/07/21	PRICE SENSITIVE	273.73KB	Share
IMM EGM - Now to be Held as an Online Virtual Meeting
15/07/21		238.59KB	Share
IMM Immutep Quarterly Activities Report & Appendix 4C
13/07/21	PRICE SENSITIVE	499.68KB	Share
IMM US FDA & IRB approves start of ph2b head & neck cancer trial
06/07/21	PRICE SENSITIVE	235.94KB	Share
IMM Proposed issue of securities - IMM
05/07/21		28.21KB	Share
IMM Change in substantial holding from AEF
30/06/21		179.63KB	Share
IMM Change in substantial holding
30/06/21		905.65KB	Share
IMM Cleansing Notice
28/06/21		233.27KB	Share
IMM Notice of Extraordinary General Meeting/Proxy Form
25/06/21		525.46KB	Share
IMM Share Purchase Plan Offer Documents
25/06/21		1.06MB	Share
IMM Application for quotation of securities - IMM
25/06/21		23.34KB	Share
IMM Efti to be evaluated in new triple combination therapy trial
21/06/21	PRICE SENSITIVE	230.43KB	Share
IMM Proposed issue of securities - IMM
21/06/21		25.41KB	Share
IMM Immutep Capital Raising Presentation
21/06/21	PRICE SENSITIVE	3.01MB	Share
IMM Immutep secures commitments for A$60 million in a Placement
21/06/21	PRICE SENSITIVE	361.64KB	Share
IMM Trading Halt
17/06/21	PRICE SENSITIVE	258.72KB	Share
IMM Change in substantial holding
15/06/21		2.25MB	Share
IMM Immutep global webcast slides
09/06/21	PRICE SENSITIVE	2.53MB	Share
IMM Appendix 2A
08/06/21		66.12KB	Share
IMM Immutep Reveals a New anti-LAG-3 Research Program
08/06/21	PRICE SENSITIVE	244.44KB	Share
IMM Application for quotation of securities - IMM
07/06/21		24.92KB	Share
IMM Immutep presentation for Jefferies Healthcare Conference
04/06/21		2.25MB	Share
IMM Immutep Reports Positive Data from its TACTI-002 ph 2 trial
04/06/21	PRICE SENSITIVE	311.58KB	Share
IMM Immutep Reports Positive Final Data from INSIGHT-004 trial
04/06/21	PRICE SENSITIVE	250.79KB	Share
IMM Immutep granted European patent for its LAG-3 candidate Efti
02/06/21	PRICE SENSITIVE	228.93KB	Share
IMM Immutep enters New Collaboration with Merck KGaA for Efti
01/06/21	PRICE SENSITIVE	234.09KB	Share
IMM Immutep granted Chinese patent for its LAG-3 candidate Efti
26/05/21	PRICE SENSITIVE	227.66KB	Share
IMM Immutep to present at Jefferies Healthcare Conference
25/05/21		215.04KB	Share
IMM TACTI-002 and INSIGHT-004 abstracts for ASCO 2021
20/05/21		309.91KB	Share
IMM Change in substantial holding
20/05/21		1.88MB	Share
IMM Change in substantial holding
18/05/21		1.9MB	Share
IMM Appendix 2A
14/05/21		285.13KB	Share
IMM Immutep Corporate Presentation
13/05/21		3.42MB	Share
IMM Operational Update
07/05/21	PRICE SENSITIVE	250.68KB	Share
IMM TACTI-002 & INSIGHT-004 data to be presented at ASCO
29/04/21	PRICE SENSITIVE	315.08KB	Share
IMM Immutep Quarterly Activities Report & Appendix 4C
19/04/21	PRICE SENSITIVE	570.75KB	Share
IMM Immutep receives A$1,155,055 R&D Tax Incentive
16/04/21	PRICE SENSITIVE	211.28KB	Share
IMM Immutep Investor Update
14/04/21		1.83MB	Share
IMM Immutep achieves Fast Track designation for Efti from US FDA
08/04/21	PRICE SENSITIVE	251.23KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 26.0¢		Change 0.000(0.00%)		Mkt cap ! $381.6M

Open	High	Low	Value	Volume
26.0¢	27.0¢	26.0¢	$408.4K	1.550M

Buyers (Bids)

No.	Vol.	Price($)
11	406961	26.0¢

Sellers (Offers)

Price($)	Vol.	No.
26.5¢	56625	2

View Market Depth

No.	Vol.	Price($)
1	9800	0.290
2	6200	0.270
12	163320	0.260
11	488619	0.255
12	218000	0.250

Price($)	Vol.	No.
0.255	495	1
0.260	15504	1
0.265	56625	1
0.270	62670	4
0.275	228818	7

Last trade - 16.10pm 12/08/2025 (20 minute delay)

IMM (ASX) Chart

IMMUTEP LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available